{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T20:21:22Z","timestamp":1773433282487,"version":"3.50.1"},"reference-count":86,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2021,5,2]],"date-time":"2021-05-02T00:00:00Z","timestamp":1619913600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Cancer and viruses have a long history that has evolved over many decades. Much information about the interplay between viruses and cell proliferation and metabolism has come from the history of clinical cases of patients infected with virus-induced cancer. In addition, information from viruses used to treat some types of cancer is valuable. Now, since the global coronavirus pandemic erupted almost a year ago, the scientific community has invested countless time and resources to slow down the infection rate and diminish the number of casualties produced by this highly infectious pathogen. A large percentage of cancer cases diagnosed are strongly related to dysregulations of the tyrosine kinase receptor (TKR) family and its downstream signaling pathways. As such, many therapeutic agents have been developed to strategically target these structures in order to hinder certain mechanisms pertaining to the phenotypic characteristics of cancer cells such as division, invasion or metastatic potential. Interestingly, several authors have pointed out that a correlation between coronaviruses such as the SARS-CoV-1 and -2 or MERS viruses and dysregulations of signaling pathways activated by TKRs can be established. This information may help to accelerate the repurposing of clinically developed anti-TKR cancer drugs in COVID-19 management. Because the need for treatment is critical, drug repurposing may be an advantageous choice in the search for new and efficient therapeutic compounds. This approach would be advantageous from a financial point of view as well, given that the resources used for research and development would no longer be required and can be potentially redirected towards other key projects. This review aims to provide an overview of how SARS-CoV-2 interacts with different TKRs and their respective downstream signaling pathway and how several therapeutic agents targeted against these receptors can interfere with the viral infection. Additionally, this review aims to identify if SARS-CoV-2 can be repurposed to be a potential viral vector against different cancer types.<\/jats:p>","DOI":"10.3390\/ijms22094830","type":"journal-article","created":{"date-parts":[[2021,5,2]],"date-time":"2021-05-02T08:05:21Z","timestamp":1619942721000},"page":"4830","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["The Interference between SARS-CoV-2 and Tyrosine Kinase Receptor Signaling in Cancer"],"prefix":"10.3390","volume":"22","author":[{"given":"Oana-Stefana","family":"Purcaru","sequence":"first","affiliation":[{"name":"Department of Biochemistry, Faculty of Medicine, University of Medicine and Pharmacy of Craiova, Str. Petru Rares nr. 2-4, 710204 Craiova, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan-Alexandru","family":"Artene","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Faculty of Medicine, University of Medicine and Pharmacy of Craiova, Str. Petru Rares nr. 2-4, 710204 Craiova, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2744-5638","authenticated-orcid":false,"given":"Edmond","family":"Barcan","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Faculty of Medicine, University of Medicine and Pharmacy of Craiova, Str. Petru Rares nr. 2-4, 710204 Craiova, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristian Adrian","family":"Silosi","sequence":"additional","affiliation":[{"name":"Department of Surgery, Faculty of Medicine, University of Medicine and Pharmacy of Craiova, Str. Petru Rares nr. 2-4, 710204 Craiova, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilona","family":"Stanciu","sequence":"additional","affiliation":[{"name":"\u201cVictor Babe\u015f\u201d Clinical Hospital of Infectious Diseases and Pneumophtisiology, Craiova, Str. Calea Bucuresti, nr. 126, 200525 Craiova, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzana","family":"Danoiu","sequence":"additional","affiliation":[{"name":"Department of Physiopathology, Faculty of Medicine, University of Medicine and Pharmacy of Craiova, Str. Petru Rares nr. 2-4, 710204 Craiova, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1079-3908","authenticated-orcid":false,"given":"Stefania","family":"Tudorache","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, University of Medicine and Pharmacy Craiova, 710204 Craiova, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6788-5833","authenticated-orcid":false,"given":"Ligia Gabriela","family":"Tataranu","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, \u201cBagdasar-Arseni\u201d Emergency Hospital, Soseaua Berceni 12, 041915 Bucharest, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3039-857X","authenticated-orcid":false,"given":"Anica","family":"Dricu","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Faculty of Medicine, University of Medicine and Pharmacy of Craiova, Str. Petru Rares nr. 2-4, 710204 Craiova, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2021,5,2]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1126\/science.1118391","article-title":"Bats Are Natural Reservoirs of SARS-Like Coronaviruses","volume":"310","author":"Li","year":"2005","journal-title":"Science"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Banerjee, A., Kulcsar, K., Misra, V., Frieman, M., and Mossman, K. (2019). Bats and Coronaviruses. Viruses, 11.","DOI":"10.3389\/fimmu.2020.00026"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","article-title":"A pneumonia outbreak associated with a new coronavirus of probable bat origin","volume":"579","author":"Zhou","year":"2020","journal-title":"Nature"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"102433","DOI":"10.1016\/j.jaut.2020.102433","article-title":"The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak","volume":"109","author":"Rothan","year":"2020","journal-title":"J. Autoimmun."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1056\/NEJMoa2001316","article-title":"Early transmission dynamics in Wuhan, China, of Novel Coronavirus\u2014Infected pneumonia","volume":"382","author":"Li","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1001\/jama.2020.2565","article-title":"Presumed Asymptomatic Carrier Transmission of COVID-19","volume":"323","author":"Bai","year":"2020","journal-title":"JAMA"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1001\/jama.2020.1585","article-title":"Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus\u2013Infected Pneumonia in Wuhan, China","volume":"323","author":"Wang","year":"2020","journal-title":"JAMA"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","article-title":"Clinical Characteristics of Coronavirus Disease 2019 in China","volume":"382","author":"Guan","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Tortorici, M.A., and Veesler, D. (2019). Structural Insights into Coronavirus Entry. Advances in Virus Research, Academic Press.","DOI":"10.1016\/bs.aivir.2019.08.002"},{"key":"ref_10","first-page":"11","article-title":"The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak\u2013an update on the status","volume":"7","author":"Guo","year":"2020","journal-title":"Mil. Med Res."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"413","DOI":"10.3201\/eid1003.030683","article-title":"Coronaviridae and SARS-associated coronavirus strain HSR1","volume":"10","author":"Vicenzi","year":"2004","journal-title":"Emerg. Infect. Dis."},{"key":"ref_12","first-page":"647","article-title":"Activation of C-Type Lectin Receptor and (RIG)-I-Like Receptors Contributes to Proinflammatory Response in Middle East Respiratory Syndrome Coronavirus-Infected Macrophages","volume":"221","author":"Zhao","year":"2019","journal-title":"J. Infect. Dis."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/jmv.25685","article-title":"Coronavirus infections and immune responses","volume":"92","author":"Li","year":"2020","journal-title":"J. Med. Virol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1126\/science.1229963","article-title":"Cyclic GMP-AMP Is an Endogenous Second Messenger in Innate Immune Signaling by Cytosolic DNA","volume":"339","author":"Wu","year":"2013","journal-title":"Science"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1600-065X.2008.00737.x","article-title":"Innate immunity to virus infection","volume":"227","author":"Takeuchi","year":"2008","journal-title":"Immunol. Rev."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Thorne, S.H., Hermiston, T., and Kirn, D. (2005). Oncolytic Virotherapy: Approaches to Tumor Targeting and Enhancing Antitumor Effects. Seminars in Oncology, W.B. Saunders Ltd.","DOI":"10.1053\/j.seminoncol.2005.09.007"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/ncponc0736","article-title":"Clinical trial results with oncolytic virotherapy: A century of promise, a decade of progress","volume":"4","author":"Liu","year":"2007","journal-title":"Nat. Clin. Pract. Oncol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s11060-008-9753-8","article-title":"Growth factor receptors signaling in glioblastoma cells: Therapeutic implications","volume":"92","author":"Carapancea","year":"2008","journal-title":"J. Neuro-Oncology"},{"key":"ref_20","first-page":"7825","article-title":"Targeting the VEGF and PDGF signaling pathway in glioblastoma treatment","volume":"8","author":"Popescu","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1096\/fba.2020-00015","article-title":"The role of growth factor receptors in viral infections: An opportunity for drug repurposing against emerging viral diseases such as COVID-19?","volume":"2","author":"Hondermarck","year":"2020","journal-title":"FASEB BioAdvances"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s11060-007-9417-0","article-title":"Dual targeting of IGF-1R and PDGFR inhibits proliferation in high-grade gliomas cells and induces radiosensitivity in JNK-1 expressing cells","volume":"85","author":"Carapancea","year":"2007","journal-title":"J. Neuro-Oncology"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"a008912","DOI":"10.1101\/cshperspect.a008912","article-title":"Receptor Tyrosine Kinases: Legacy of the First Two Decades","volume":"6","author":"Schlessinger","year":"2014","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/nrc3309","article-title":"The ERBB network: At last, cancer therapy meets systems biology","volume":"12","author":"Yarden","year":"2012","journal-title":"Nat. Rev. Cancer"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"50209","DOI":"10.18632\/oncotarget.16854","article-title":"Epidermal growth factor receptor (EGFR): A rising star in the era of precision medicine of lung cancer","volume":"8","author":"Liu","year":"2017","journal-title":"Oncotarget"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.virol.2018.05.009","article-title":"Epidermal growth factor receptor is a co-factor for transmissible gastroenteritis virus entry","volume":"521","author":"Hu","year":"2018","journal-title":"Virology"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"12206","DOI":"10.18632\/oncotarget.7723","article-title":"The epidermal growth factor receptor regulates cofilin activity and promotes transmissible gastroenteritis virus entry into intestinal epithelial cells","volume":"7","author":"Hu","year":"2016","journal-title":"Oncotarget"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"104651","DOI":"10.1016\/j.antiviral.2019.104651","article-title":"Receptor tyrosine kinase inhibitors block proliferation of TGEV mainly through p38 mitogen-activated protein kinase pathways","volume":"173","author":"Dong","year":"2020","journal-title":"Antivir. Res."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Venkataraman, T., Coleman, C.M., and Frieman, M.B. (2017). Overactive Epidermal Growth Factor Receptor Signaling Leads to Increased Fibrosis after Severe Acute Respiratory Syndrome Coronavirus Infection. J. Virol., 91.","DOI":"10.1128\/JVI.00182-17"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1007\/s40264-016-0450-9","article-title":"Tyrosine Kinase Inhibitor-Induced Interstitial Lung Disease: Clinical Features, Diagnostic Challenges, and Therapeutic Dilemmas","volume":"39","author":"Shah","year":"2016","journal-title":"Drug Saf."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"e129","DOI":"10.1016\/j.jtho.2020.04.029","article-title":"EGFR Tyrosine Kinase Inhibitor\u2013Associated Interstitial Lung Disease during the Coronavirus Disease 2019 Pandemic","volume":"15","author":"Chang","year":"2020","journal-title":"J. Thorac. Oncol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1111\/j.1440-1843.2006.00940.x","article-title":"Clinical aspects of epidermal growth factor receptor inhibitors: Benefit and risk","volume":"11","author":"Kato","year":"2006","journal-title":"Respirology"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Totura, A.L., Whitmore, A.C., Agnihothram, S., Sch\u00e4fer, A., Katze, M.G., Heise, M.T., and Baric, R.S. (2015). Toll-Like Receptor 3 Signaling via TRIF Contributes to a Protective Innate Immune Response to Severe Acute Respiratory Syndrome Coronavirus Infection. MBio, 6.","DOI":"10.1128\/mBio.00638-15"},{"key":"ref_34","first-page":"5054","article-title":"Epidermal growth factor receptor tyrosine kinase inhibition augments a murine model of pulmonary fibrosis","volume":"63","author":"Suzuki","year":"2003","journal-title":"Cancer Res."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"41991","DOI":"10.1074\/jbc.M112.356824","article-title":"Amphiregulin, an Epidermal Growth Factor Receptor Ligand, Plays an Essential Role in the Pathogenesis of Transforming Growth Factor-\u03b2-induced Pulmonary Fibrosis","volume":"287","author":"Zhou","year":"2012","journal-title":"J. Biol. Chem."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"L1217","DOI":"10.1152\/ajplung.00020.2008","article-title":"EGF receptor tyrosine kinase inhibitors diminish transforming growth factor-\u03b1-induced pulmonary fibrosis","volume":"294","author":"Hardie","year":"2008","journal-title":"Am. J. Physiol.-Lung Cell. Mol. Physiol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.antiviral.2017.03.022","article-title":"The role of epidermal growth factor receptor (EGFR) signaling in SARS coronavirus-induced pulmonary fibrosis","volume":"143","author":"Venkataraman","year":"2017","journal-title":"Antivir. Res."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/gb-2001-2-3-reviews3005","article-title":"Fibroblast growth factors","volume":"2","author":"Ornitz","year":"2001","journal-title":"Genome Biol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.tig.2004.08.007","article-title":"Evolution of the Fgf and Fgfr gene families","volume":"20","author":"Itoh","year":"2004","journal-title":"Trends Genet."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.critrevonc.2017.02.018","article-title":"FGFR a promising druggable target in cancer: Molecular biology and new drugs","volume":"113","author":"Porta","year":"2017","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/(SICI)1521-1878(200002)22:2<108::AID-BIES2>3.0.CO;2-M","article-title":"FGFs, heparan sulfate and FGFRs: Complex interactions essential for development","volume":"22","author":"Ornitz","year":"2000","journal-title":"BioEssays"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/4758","article-title":"Human fibroblast growth factor receptor 1 is a co-receptor for infection by adeno-associated virus 2","volume":"5","author":"Qing","year":"1999","journal-title":"Nat. Med."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/nature08699","article-title":"Human host factors required for influenza virus replication","volume":"463","author":"Stertz","year":"2010","journal-title":"Nature"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1016\/j.celrep.2019.04.105","article-title":"Reciprocal Effects of Fibroblast Growth Factor Receptor Signaling on Dengue Virus Replication and Virion Production","volume":"27","author":"Cortese","year":"2019","journal-title":"Cell Rep."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1093\/infdis\/jiz073","article-title":"Fibroblast Growth Factor 2 Enhances Zika Virus Infection in Human Fetal Brain","volume":"220","author":"Limonta","year":"2019","journal-title":"J. Infect. Dis."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1002\/path.4575","article-title":"Activation of the FGFR1 signalling pathway by the Epstein-Barr virus-encoded LMP1 promotes aerobic glycolysis and transformation of human nasopharyngeal epithelial cells","volume":"237","author":"Lo","year":"2015","journal-title":"J. Pathol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"16004","DOI":"10.1038\/nmicrobiol.2016.4","article-title":"MERS coronavirus induces apoptosis in kidney and lung by upregulating Smad7 and FGF2","volume":"1","author":"Yeung","year":"2016","journal-title":"Nat. Microbiol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1016\/j.bbapap.2012.10.015","article-title":"Platelet-derived growth factors and their receptors: Structural and functional perspectives","volume":"1834","author":"Chen","year":"2013","journal-title":"Biochim. Biophys. Acta\u2014Proteins Proteom."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.cytogfr.2004.03.010","article-title":"PDGF receptor kinase inhibitors for the treatment of PDGF driven diseases","volume":"15","author":"Levitzki","year":"2004","journal-title":"Cytokine Growth Factor Rev."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1099\/jgv.0.001235","article-title":"Influenza virus entry via the GM3 ganglioside-mediated platelet-derived growth factor receptor \u03b2 signalling pathway","volume":"100","author":"Vrijens","year":"2019","journal-title":"J. Gen. Virol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"E9889","DOI":"10.1073\/pnas.1806305115","article-title":"Role of PDGF receptor-\u03b1 during human cytomegalovirus entry into fibroblasts","volume":"115","author":"Wu","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Wu, Y., Prager, A., Boos, S., Resch, M., Brizic, I., Mach, M., Wildner, S., Scrivano, L., and Adler, B. (2017). Human cytomegalovirus glycoprotein complex gH\/gL\/gO uses PDGFR-\u03b1 as a key for entry. PLoS Pathog., 13.","DOI":"10.1371\/journal.ppat.1006281"},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Liu, J., Jardetzky, T.S., Chin, A.L., Johnson, D.C., and Vanarsdall, A.L. (2018). The Human Cytomegalovirus Trimer and Pentamer Promote Sequential Steps in Entry into Epithelial and Endothelial Cells at Cell Surfaces and Endosomes. J. Virol., 92.","DOI":"10.1128\/JVI.01336-18"},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Allegra, A., Pioggia, G., Tonacci, A., Musolino, C., and Gangemi, S. (2020). Cancer and SARS-CoV-2 Infection: Diagnostic and Therapeutic Challenges. Cancers, 12.","DOI":"10.3390\/cancers12020524"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/S1470-2045(20)30230-8","article-title":"The UK Coronavirus Cancer Monitoring Project: Protecting patients with cancer in the era of COVID-19","volume":"21","author":"Anil","year":"2020","journal-title":"Lancet Oncol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"L52","DOI":"10.1152\/ajplung.00047.2018","article-title":"Inhibiting Bruton\u2019s tyrosine kinase rescues mice from lethal influenza-induced acute lung injury","volume":"315","author":"Florence","year":"2018","journal-title":"Am. J. Physiol.-Lung Cell. Mol. Physiol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1182\/blood.2020006288","article-title":"The BTK inhibitor ibrutinib may protect against pulmonary injury in COVID-19\u2013infected patients","volume":"135","author":"Treon","year":"2020","journal-title":"Blood"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"eabd0110","DOI":"10.1126\/sciimmunol.abd0110","article-title":"Inhibition of Bruton tyrosine kinase in patients with severe COVID-19","volume":"5","author":"Roschewski","year":"2020","journal-title":"Sci. Immunol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.clml.2019.08.011","article-title":"Selective inhibitors of nuclear export in the treatment of hematologic malignancies","volume":"19","author":"Allegra","year":"2019","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"key":"ref_60","unstructured":"Agree, I. (2021, May 01). Karyopharm to Evaluate Low Dose Selinexor as a Potential Treatment for Hospitalized Patients with COVID-19. Available online: https:\/\/www.globenewswire.com\/news-release\/2020\/04\/07\/2012711\/0\/en\/Karyopharm-to-Evaluate-Low-Dose-Selinexor-as-a-Potential-Treatment-for-Hospitalized-Patients-with-COVID-19.html."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1089\/dna.2017.4033","article-title":"Repurposing of Kinase Inhibitors as Broad-Spectrum Antiviral Drugs","volume":"37","author":"Schor","year":"2018","journal-title":"DNA Cell Biol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1128\/AAC.03659-14","article-title":"Antiviral Potential of ERK\/MAPK and PI3K\/AKT\/mTOR Signaling Modulation for Middle East Respiratory Syndrome Coronavirus Infection as Identified by Temporal Kinome Analysis","volume":"59","author":"Kindrachuk","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"8924","DOI":"10.1128\/JVI.01429-16","article-title":"Abelson Kinase Inhibitors Are Potent Inhibitors of Severe Acute Respiratory Syndrome Coronavirus and Middle East Respiratory Syndrome Coronavirus Fusion","volume":"90","author":"Coleman","year":"2016","journal-title":"J. Virol."},{"key":"ref_64","first-page":"68","article-title":"Imatinib a Tyrosine Kinase Inhibitor: A potential treatment for SARS- COV-2 induced pneumonia","volume":"56","author":"Assaad","year":"2020","journal-title":"Alex. J. Med."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1183\/09031936.00054407","article-title":"Possible role of imatinib in clinical pulmonary veno-occlusive disease","volume":"32","author":"Overbeek","year":"2008","journal-title":"Eur. Respir. J."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"AB169","DOI":"10.1016\/j.jaci.2016.12.553","article-title":"Effect of KIT Inhibition by Imatinib on Airway Mast Cells in Patients with Severe Refractory Asthma (KIA)","volume":"139","author":"Cahill","year":"2017","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1161\/CIRCULATIONAHA.112.000765","article-title":"Imatinib mesylate as add-on therapy for pulmonary arterial hypertension: Results of the randomized IMPRES study","volume":"127","author":"Hoeper","year":"2013","journal-title":"Circulation"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1164\/rccm.200906-0964OC","article-title":"Imatinib treatment for idiopathic pulmonary fibrosis: Randomized placebo-controlled trial results","volume":"181","author":"Daniels","year":"2010","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Mulgaonkar, N.S., Wang, H., Mallawarachchi, S., Ruzek, D., Martina, B., and Fernando, S. (2020). Bcr-Abl tyrosine kinase inhibitor imatinib as a potential drug for COVID-19. bioRxiv.","DOI":"10.1101\/2020.06.18.158196"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"L1294","DOI":"10.1152\/ajplung.00031.2015","article-title":"Imatinib attenuates inflammation and vascular leak in a clinically relevant two-hit model of acute lung injury","volume":"309","author":"Rizzo","year":"2015","journal-title":"Am. J. Physiol.-Lung Cell. Mol. Physiol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.virusres.2009.01.005","article-title":"Collins, SARS coronavirus spike protein-induced innate immune response occurs via activation of the NF-\u03baB pathway in human monocyte macrophages in vitro","volume":"142","author":"Dosch","year":"2009","journal-title":"Virus Res."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"108518","DOI":"10.1016\/j.clim.2020.108518","article-title":"Imatinib for COVID-19: A case report","volume":"218","year":"2020","journal-title":"Clin. Immunol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"e223","DOI":"10.1016\/j.jaad.2020.03.099","article-title":"The use of Janus kinase inhibitors in the time of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)","volume":"82","author":"Peterson","year":"2020","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.bbadis.2007.12.005","article-title":"Viruses associated with human cancer","volume":"1782","author":"Munger","year":"2008","journal-title":"Biochim. Biophys. Acta\u2014Mol. Basis Dis."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"110009","DOI":"10.1016\/j.mehy.2020.110009","article-title":"Can COVID-19 induce glioma tumorogenesis through binding cell receptors?","volume":"144","author":"Khan","year":"2020","journal-title":"Med. Hypotheses"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/s41593-020-00771-8","article-title":"The S1 protein of SARS-CoV-2 crosses the blood-brain barrier in mice","volume":"24","author":"Rhea","year":"2021","journal-title":"Nat. Neurosci."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.stem.2020.10.001","article-title":"SARS-CoV-2 Infects the Brain Choroid Plexus and Disrupts the Blood-CSF Barrier in Human Brain Organoids","volume":"27","author":"Pellegrini","year":"2020","journal-title":"Cell Stem Cell"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.annonc.2020.03.296","article-title":"Clinical characteristics of COVID-19-infected cancer patients: A retrospective case study in three hospitals within Wuhan, China","volume":"31","author":"Zhang","year":"2020","journal-title":"Ann. Oncol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12885-019-5353-6","article-title":"Cancer-associated fibroblasts induce epithelial\u2013mesenchymal transition of bladder cancer cells through paracrine IL-6 signalling","volume":"19","author":"Goulet","year":"2019","journal-title":"BMC Cancer"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1158\/0008-5472.CAN-10-1496","article-title":"IL-6 Trans-Signaling in Formation and Progression of Malignant Ascites in Ovarian Cancer","volume":"71","author":"Lo","year":"2010","journal-title":"Cancer Res."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1099\/0022-1317-83-3-491","article-title":"Cytolytic viruses as potential anti-cancer agents","volume":"83","author":"Ring","year":"2002","journal-title":"J. Gen. Virol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"11800","DOI":"10.1038\/s41598-018-30296-x","article-title":"Comparative effect of immunotherapy and standard therapy in patients with high grade glioma: A meta-analysis of published clinical trials","volume":"8","author":"Artene","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"6669","DOI":"10.2147\/OTT.S112842","article-title":"Dendritic cell immunotherapy versus bevacizumab plus irinotecan in recurrent malignant glioma patients: A survival gain analysis","volume":"9","author":"Artene","year":"2016","journal-title":"OncoTargets Ther."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2012\/798526","article-title":"Retargeting of Viruses to Generate Oncolytic Agents","volume":"2012","author":"Verheije","year":"2011","journal-title":"Adv. Virol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"15314","DOI":"10.1128\/JVI.79.24.15314-15322.2005","article-title":"Soluble Receptor-Mediated Targeting of Mouse Hepatitis Coronavirus to the Human Epidermal Growth Factor Receptor","volume":"79","author":"Verheije","year":"2005","journal-title":"J. Virol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"7507","DOI":"10.1128\/JVI.00495-09","article-title":"Coronavirus Genetically Redirected to the Epidermal Growth Factor Receptor Exhibits Effective Antitumor Activity against a Malignant Glioblastoma","volume":"83","author":"Verheije","year":"2009","journal-title":"J. Virol."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/9\/4830\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T05:56:41Z","timestamp":1760162201000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/9\/4830"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,2]]},"references-count":86,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2021,5]]}},"alternative-id":["ijms22094830"],"URL":"https:\/\/doi.org\/10.3390\/ijms22094830","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,2]]}}}